Immix BiopharmaIMMX
13F holders, Q2 2025 (June 30)23holders +1
5new positions
4sold out
$2.07avg. 13F price*
At the end of Q2 2025, 23 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, up 1 from Q1 2025. 5 opened new positions and 4 sold out. The largest holders were Bleichroeder LP ($1.8M), Vanguard Group Inc. ($1.4M) and Geode Capital Management, LLC ($334K).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $164K |
| Exits | 4 | $1.3M |
All 13F filers, Q1 2025 → Q2 2025: 154,412 shares bought and 810,626 shares sold, net −656,214 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Bleichroeder LP | 0.43% | No change | 850,000 | $1.8M |
| Vanguard Group Inc. | 0.00% | No change | 698,537 | $1.4M |
| Geode Capital Management, LLC | 0.00% | Add +0.2% | 161,115 | $334K |
| Morgan Stanley | 0.00% | Add +51.8% | 124,919 | $259K |
| Northern Trust Corp. | 0.00% | Reduce -1.4% | 93,888 | $194K |
| Susquehanna International Group, LLP | 0.00% | Reduce -8.0% | 50,826 | $105K |
| State Street Corp. | 0.00% | No change | 42,960 | $89K |
| BlackRock, Inc. | 0.00% | Add +240.8% | 40,301 | $83K |
| Private Advisor Group, LLC | 0.00% | No change | 31,225 | $65K |
| Tocqueville Asset Management L.P. | 0.00% | No change | 29,300 | $61K |
| Velan Capital Investment Management LP | 0.05% | New | 25,000 | $52K |
| Tritonpoint Wealth, LLC | 0.00% | New | 24,526 | $51K |
| Virtu Financial LLC | 0.00% | New | 17,846 | $37K |
| SBI Securities Co., Ltd. | 0.00% | No change | 17,500 | $36K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -5.9% | 16,040 | $33K |
| UBS Group AG | 0.00% | Add +38.0% | 13,972 | $29K |
| Focus Partners Wealth | 0.00% | No change | 11,900 | $25K |
| Royal Bank of Canada | 0.00% | New | 11,168 | $23K |
| Raymond James Financial Inc. | 0.00% | New | 525 | $1K |
| Wells Fargo & Company | 0.00% | No change | 330 | $683 |
| Bank of America Corp. | 0.00% | Add +15.8% | 139 | $288 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -72.2% | 131 | $271 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 80 | $166 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.